Back to Search
LANCE GODLEY, D.M.D.
D.M.D.
General Practice Dentistry
NPI: 1609133172Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
DN14581(FL)20150002205(MO)DEN.00009153(CO)
Research & Publications (20)
Deletion of the der(9q) in chronic myeloid leukemia: the controversy continues.
PMID 19479615·Leuk Lymphoma·2009
8-other
HMGA2 levels in CML: reflective of miRNA gene regulation in a hematopoietic tumor?
PMID 17917958·Leuk Lymphoma·2007
7-preclinical
High levels of tRNA abundance and alteration of tRNA charging by bortezomib in multiple myeloma.
PMID 19450555·Biochem Biophys Res Commun·2009
8-other
Allogeneic stem cell transplantation with alemtuzumab-based conditioning for patients with advanced chronic myelogenous leukemia.
PMID 19142796·Leuk Lymphoma·2009
8-other
Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial.
PMID 19528372·J Clin Oncol·2009
3-trial
A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia.
PMID 18425419·Invest New Drugs·2008
3-trial
A phase I biological study of MG98, an oligodeoxynucleotide antisense to DNA methyltransferase 1, in patients with high-risk myelodysplasia and acute myeloid leukemia.
PMID 18413836·Clin Cancer Res·2008
3-trial
Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products.
PMID 18297531·Leuk Lymphoma·2008
8-other
Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation.
PMID 18940674·Biol Blood Marrow Transplant·2008
8-other
The identification and characterisation of novel KIT transcripts in aggressive mast cell malignancies and normal CD34+ cells.
PMID 18766971·Leuk Lymphoma·2008
8-other
Implications of FLT3 mutations in the therapy of acute myeloid leukemia.
PMID 18473998·Rev Recent Clin Trials·2007
6-review
Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation.
PMID 17846595·Bone Marrow Transplant·2007
3-trial
Successful allogeneic transplantation of patients with suspected prior invasive mold infection.
PMID 17786717·Leuk Lymphoma·2007
8-other
The use of hypomethylating agents in the treatment of hematologic malignancies.
PMID 17786703·Leuk Lymphoma·2007
6-review
Cancer cells express aberrant DNMT3B transcripts encoding truncated proteins.
PMID 17353906·Oncogene·2007
8-other
Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation.
PMID 16920562·Biol Blood Marrow Transplant·2006
3-trial
Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning.
PMID 16400339·Bone Marrow Transplant·2006
3-trial
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome.
PMID 16009946·J Clin Oncol·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 20900 E QUINCY DR
AURORA, CO 80015 - Phone
- (303) 724-5525
Quick Facts
- NPI
- 1609133172
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile